A61K 38 - Medicinal preparations containing peptides

Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
12/2009
12/10/2009	US20090305984 Engineered CXCL 12 alpha locked dimer polypeptide
12/10/2009	US20090305983 Curable Bone Cement
12/10/2009	US20090305982 Muteins of tear lipocalin and methods for obtaining the same
12/10/2009	US20090305981 Secreted protein acidic and rich in cysteine (sparc) as chemotherapeutic sensitizers
12/10/2009	US20090305980 Methods and Compositions Related to TR4
12/10/2009	US20090305979 Compositions comprising hpv polypeptides and immunoenhancement peptides for the treatment and prevention of cervical cancer
12/10/2009	US20090305978 Methods for increasing the size of animals using needleless delivery constructs
12/10/2009	US20090305977 Method for treating peripheral arterial disease with zinc finger proteins
12/10/2009	US20090305976 Cytokine Mediating Composition
12/10/2009	US20090305975 Use of Trap Protein Per se as an Active Ingredient for the Manufacture of a Medicament for the Treatment of Staphylococcus Aureus Infection
12/10/2009	US20090305974 Therapeutic indications of colony stimulating factors
12/10/2009	US20090305973 Novel peptide and use thereof
12/10/2009	US20090305972 Novel cancer-associated antigen
12/10/2009	US20090305971 Nogo-B Receptor
12/10/2009	US20090305970 Toxin-Like Polypeptides, Polynucleotides Encoding Same and Uses Thereof
12/10/2009	US20090305969 Skin Repair Accelerating Therapeutic Agent Containing Desacyl Ghrelin and Derivatives Thereof as Active Ingredient
12/10/2009	US20090305968 Cell-Permeable Peptide Inhibitors of the JNK Signal Transduction Pathway
12/10/2009	US20090305967 Glycopegylated factor vii and factor viia
12/10/2009	US20090305966 Use of histones for therapeutic purposes
12/10/2009	US20090305965 Stabilized Parathyroid Hormone Composition Comprising Parathyroid Hormone, Buffer and Stabilizing Agent
12/10/2009	US20090305964 Pharmaceutical preparations of a glp-1 molecule and an anti-emetic drug
12/10/2009	US20090305963 Lipocalin 2 for the Treatment, Prevention, and Management of Cancer Metastasis, Angiogenesis, and Fibrosis
12/10/2009	US20090305962 Low density lipoprotein receptor fusion for use in prevention and treatment of inflammation and autoimmune diseases
12/10/2009	US20090305961 Novel chimeric plasminogen activators and their pharmaceutical use
12/10/2009	US20090305960 Melanocortin Receptor-Specific Peptides for Treatment of Obesity / 669
12/10/2009	US20090305959 Use of Peptidic Vasopressin Receptor Agonists
12/10/2009	US20090305958 Stabilizing alkylglycoside compositions and methods thereof
12/10/2009	US20090305957 Preparation of biodegradable polyesters with low-burst properties by supercritical fluid extraction
12/10/2009	US20090305956 Treatment of Ras-Expressing Tumors
12/10/2009	US20090305955 Cyclopeptide with Anti-Cancer Activity Derived from Collagen Type IV
12/10/2009	US20090305954 Histidine-containing diastereomeric peptides and uses thereof
12/10/2009	US20090305953 Dalbavancin compositions for treatment of bacterial infections
12/10/2009	US20090305952 Anionic polyamide functionalized with a tryptophan unit
12/10/2009	US20090305951 Compounds capable of affecting differentiation, proliferation, regeneration, plasticity and survival cells
12/10/2009	US20090305950 Multimer of extracellular domain of cell surface functional molecule
12/10/2009	US20090305949 Glycosylated specificity exchanger
12/10/2009	US20090305948 Branched Polyamino Acids Functionalized with Hydrophobic Groups, and Applications Thereof Particularly Therapeutic Applications
12/10/2009	US20090305947 Livestock management for improved reproductive efficiency
12/10/2009	US20090305946 presenilin/G-protein/c-src binding polypeptides ; modulate the physiologic interactions of polypeptides required for the production of beta -amyloid (A beta )
12/10/2009	US20090305945 Novel nutraceutical compositions
12/10/2009	US20090305944 Methods for Providing Palliative Care with AVR 118
12/10/2009	US20090305418 Cell therapy method for the treatment of tumors
12/10/2009	US20090305411 Recombinant antibodies and immunoconjugates targeted to cd-22 bearing cells and tumors
12/10/2009	US20090305400 Modified chaperonin 10
12/10/2009	US20090305365 Fad4, fad5, fad5-2, and fad6, novel fatty acid desaturase family members and uses thereof
12/10/2009	US20090305350 Gene Differentially Expressed in Breast and Bladder Cancer and Encoded Polypeptides
12/10/2009	US20090305344 Chimeric alphavirus replicon particles
12/10/2009	US20090305340 Altered peptide ligands of gad65
12/10/2009	US20090305289 Screening method to identify protective substances for the treatment of neurodegenerative and/or ischaemic diseases
12/10/2009	US20090304818 Method of treatment
12/10/2009	US20090304817 Glycosylation Variants of Ricin-Like Proteins
12/10/2009	US20090304814 Fibrillation resistant proteins
12/10/2009	US20090304809 Dental fillers, methods, compositions including a caseinate
12/10/2009	US20090304804 Biologic devices for hemostasis
12/10/2009	US20090304783 Compositions and methods for treating bacteria
12/10/2009	US20090304781 Master gene of arteriogenesis
12/10/2009	US20090304776 Transmucosal delivery of therapeutic agents and methods of use thereof
12/10/2009	US20090304768 Gastro-Retentive System for the Delivery of Macromolecules
12/10/2009	US20090304765 R-ras activity in vascular regulation
12/10/2009	US20090304754 Pegylated glutenase polypeptides
12/10/2009	US20090304752 Hypoallergenic variants of the major allergen from betula verrucosa pollen
12/10/2009	US20090304748 Clostridial toxin pharmaceutical compositions
12/10/2009	US20090304746 Inducing cellar immune responses to hepatitis C virus using peptide and nucleic acid compositions
12/10/2009	US20090304724 Compositions and Methods for Stimulating Gastrointestinal Motility
12/10/2009	US20090304722 Chlamydia trachomatis antigens for vaccine and diagnostic use
12/10/2009	US20090304720 Active Agent-Loaded Nanoparticles Based On Hydrophilic Proteins
12/10/2009	US20090304719 Activatable binding polypeptides and methods of identification and use thereof
12/10/2009	US20090304708 Preparation for the Prevention and/or Treatment of a Tissue Change of Mesenchymal Origin
12/10/2009	US20090304703 Compositions and methods for the diagnosis and treatment of immune disorders
12/10/2009	US20090304702 Gene expressed in prostate cancer and methods of use
12/10/2009	US20090304699 Methods of treating fibrosis
12/10/2009	US20090304698 Modulation of ovulation
12/10/2009	US20090304691 Antagonists of bmp9, bmp10, alk1 and other alk1 ligands, and uses thereof
12/10/2009	US20090304686 Interfering in activation of an immune cell by influencing interaction of lair and collagen
12/10/2009	US20090304683 Soluble Fragments of The Sars-Cov Spike Glycoprotein
12/10/2009	US20090304682 Multiple-variable dose regimen for treating TNFa-related disorders
12/10/2009	US20090304676 Compositions and methods for enhancing cognitive function
12/10/2009	US20090304675 Method of modulation of mullerian inhibitory substance (mis) receptor for the treatment of neurodegenerative diseases
12/10/2009	US20090304674 Methods for treating disease by regulating cll cell survival
12/10/2009	US20090304673 Method of Treatment of Inflammatory Diseases
12/10/2009	US20090304672 Adamts13 genes and proteins and variants, and therapeutic compositions and methods of utilizing the same
12/10/2009	US20090304671 Method of treating endothelial dysfunction
12/10/2009	US20090304670 Food product comprising a proline specific protease, the preparation thereof and its use for degrading toxic or allergenic gluten peptides
12/10/2009	US20090304669 Preparative purification process for human furin
12/10/2009	US20090304668 Larval polypeptides having a nuclease activity
12/10/2009	US20090304667 Method of Regulating Mammalian Target-of-Rapamycin Activity by Interaction Between Phospholipase D and RHEB
12/10/2009	US20090304666 Conjugate for the specific targeting of anticancer agents to tumor cells or tumor vasculature and production thereof
12/10/2009	US20090304665 Super fast-acting insulin compositions
12/10/2009	US20090304664 Modulators of alpha-synuclein toxicity
12/10/2009	US20090304663 Use of gsk-3 inhibitors for the treatment of prostate cancer
12/10/2009	US20090304662 Methods for Identifying and Targeting Tumor Stem Cells Based on Nuclear Morphology
12/10/2009	US20090304661 Method And Composition For Proctecting Neuronal Tissue From Damage Induced By Elevated Glutamate Levels
12/10/2009	US20090304660 G-csf derivative for inducing immunological tolerance
12/10/2009	US20090304651 Insulin-Like Growth Factor II (IGF-II) Binding Factors
12/10/2009	US20090304635 Methods for generating new hair follicles, treating baldness, and hair removal
12/10/2009	US20090304634 Novel Combinations
12/10/2009	US20090304633 Chimeric vaccine antigens against classical swine fever virus
12/10/2009	US20090304632 HETEROCYCLIC NF-kB INHIBITORS
12/10/2009	US20090304631 Hepatitis c serine protease inhibitors and uses therefor
12/10/2009	US20090304630 Treating severe and acute viral infections

1 ... 697 698 699 700 701 702 703 704 705 706 707 708 709 710 711 712 713 714 715 716 717 ... 3163